Key result
The novel recombinant pseudorabies virus strain HN2201 exhibited attenuated virulence in 9-week-old piglets, characterized by transient clinical signs.
A novel recombinant pseudorabies virus strain (HN2201) isolated in China shows attenuated virulence and highlights the potential for recombination between classical and vaccine strains.
Answers are grounded in this paper and cite their sources.
Novel recombinant PRV HN2201 isolated from stillbirth; leaves open recombination risks and surveillance needs in vaccinated swine.
Pseudorabies (PR) remains one of the most important swine diseases in China. Live attenuated vaccines have been widely deployed and have proven highly effective in controlling PR in the field. However, recent concerns regarding the evolution and recombination events involving pseudorabies virus (PRV) vaccine strains have raised substantial attention. In the present study, a novel recombinant PRV strain named HN2201 was isolated from one stillbirth case in Henan province in 2022. To assess the genetic and evolutionary features, the major immunogenic and virulence-associated genes, including gB, gC, gD, gG, gE and TK, were sequenced and analyzed. Phylogenetic and nucleotide homology analysis revealed that gB, gC, gD and gG genes of HN2201 displayed close relationship with Chinese classical strains. However, the TK gene of HN2201 contained a continuous deletion of 205 nucleotides, sharing the highest nucleotide homology (99.9%) with HB-98 vaccine strain. Additionally, a similar deletion was observed in the promoter region of the gE gene in both HN2201 and HB-98. Pathogenicity studies on 9-week-old piglets demonstrated that HN2201 exhibited attenuated virulence, characterized by transient clinical signs. The above results suggest that the naturally isolated HN2201 likely resulted from recombination events between the PRV classical strain and the HB-98 vaccine strain. Our findings provide valuable insights into the evolution of PRV in China and underscore the necessity of scientific and cautious use of PRV vaccines in the field.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied Pseudorabies. Novel recombinant PRV strain HN2201 was evaluated on Pathogenicity and clinical signs. The novel recombinant pseudorabies virus strain HN2201 exhibited attenuated virulence in 9-week-old piglets, characterized by transient clinical signs.
Synapse has enriched 10 related papers. Consider them for comparative context: